ITRM vs MA · rev $390.0K vs P/E 38, rev $32.79B
Iterum Therapeutics PLC (ITRM) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
ITRM currently screens at market cap $38.6M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the ITRM and MA stock pages for the full models.
Not investment advice.